N | GG | AOR (95%CI)Δ | PvalueΔ | GA | AOR (95%CI)Δ | PvalueΔ | AA | AOR (95%CI)Δ PvalueΔ | G | A | AOR (95%CI)* | Pvalue* | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Clinical Stage | |||||||||||||
III + IV | 128 | 33(25.8) | 2.27(1.11 ~ 4.66) | 0.025 | 62(48.4) | 1.55(0.87 ~ 2.78) | 0.139 | 33(25.8) | - | 128(50.0) | 128(50.0) | 1.86(1.22 ~ 2.82) | 0.004 |
I + II | 120 20(16.7) | - | 55(45.8) | - | 45(37.5) | - | 95(39.6) | 145(60.4) | - | ||||
Tumor differentiation | |||||||||||||
Poor | 118 | 29(24.6) | 1.34(0.66-2.70) | 0.418 | 52(44.1) | 0.89(0.50 ~ 1.58) | 0.680 | 37(31.4) | - | 110(46.6) | 126(53.4) | 1.08(0.71 ~ 1.63) | 0.729 |
Well & moderate | 130 | 24(18.5) | - | 65(50.0) | - | 41(31.5) | - | 113(43.5) | 147(56.5) | - | |||
Lymph node status | |||||||||||||
Positive | 111 | 29(26.1) | 2.90 (1.40 ~ 6.03) | 0.004 | 59(53.2) | 2.44(1.33-4.50) | 0.004 | 23(20.7) | - | 117(52.7) | 105(47.3) | 2.67(1.72 ~ 4.13) | 0.001 |
Negative | 137 | 24(17.5) | - | 58(42.3) | - | 55(40.1) | 106(38.7) | 168(61.3) | - | ||||
Serosa invasion | |||||||||||||
Positive | 126 | 34(27.0) | 2.78(1.34 ~ 5.75) | 0.006 | 62(49.2) | 1.74(0.97-3.13) | 0.064 | 30(23.8) | - | 130(51.6) | 122 (48.4) | 2.17(1.42 ~ 3.31) | 0.001 |
Negative | 122 | 19(15.6) | - | 55(45.1) | 48(39.3) | - | 93(38.1) | 151 (61.9) | - |